Ramzi Abboud

897 total citations
28 papers, 527 citations indexed

About

Ramzi Abboud is a scholar working on Hematology, Immunology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Ramzi Abboud has authored 28 papers receiving a total of 527 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Hematology, 11 papers in Immunology and 9 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Ramzi Abboud's work include Hematopoietic Stem Cell Transplantation (20 papers), Acute Lymphoblastic Leukemia research (9 papers) and Immune Cell Function and Interaction (8 papers). Ramzi Abboud is often cited by papers focused on Hematopoietic Stem Cell Transplantation (20 papers), Acute Lymphoblastic Leukemia research (9 papers) and Immune Cell Function and Interaction (8 papers). Ramzi Abboud collaborates with scholars based in United States, Italy and Colombia. Ramzi Abboud's co-authors include RF Coburn, John F. DiPersio, Xiaojie Li, Duane C. Hassane, Martin Carroll, Craig T. Jordan, Cheryl A. Corbett, Mónica L. Guzmán, Fay Young and Jane L. Liesveld and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Frontiers in Immunology.

In The Last Decade

Ramzi Abboud

28 papers receiving 517 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ramzi Abboud United States	9	227	176	173	134	51	28	527
Enrique Colado Spain	16	327 1.4×	241 1.4×	159 0.9×	165 1.2×	43 0.8×	35	683
Élodie Lainey France	13	182 0.8×	225 1.3×	148 0.9×	87 0.6×	35 0.7×	30	501
Qun Hu China	11	118 0.5×	278 1.6×	137 0.8×	42 0.3×	25 0.5×	78	628
Tomohiro Kubo Japan	12	115 0.5×	110 0.6×	80 0.5×	163 1.2×	20 0.4×	32	513
Mohamed Elhamri France	14	323 1.4×	181 1.0×	159 0.9×	28 0.2×	114 2.2×	44	507
Malte Roerden Germany	12	56 0.2×	197 1.1×	140 0.8×	189 1.4×	13 0.3×	22	538
Jia Gu China	12	63 0.3×	184 1.0×	116 0.7×	99 0.7×	10 0.2×	33	428
Emanuela Campalani United Kingdom	8	53 0.2×	165 0.9×	78 0.5×	374 2.8×	91 1.8×	14	593
A Oliff United States	7	105 0.5×	229 1.3×	170 1.0×	144 1.1×	28 0.5×	8	638
Cristina Tassi Italy	14	196 0.9×	113 0.6×	70 0.4×	164 1.2×	20 0.4×	38	438

Countries citing papers authored by Ramzi Abboud

Since Specialization

Citations

This map shows the geographic impact of Ramzi Abboud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ramzi Abboud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ramzi Abboud more than expected).

Fields of papers citing papers by Ramzi Abboud

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ramzi Abboud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ramzi Abboud. The network helps show where Ramzi Abboud may publish in the future.

Co-authorship network of co-authors of Ramzi Abboud

This figure shows the co-authorship network connecting the top 25 collaborators of Ramzi Abboud. A scholar is included among the top collaborators of Ramzi Abboud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ramzi Abboud. Ramzi Abboud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Modi, Dipenkumar, Yosra Aljawai, Todd E. DeFor, et al.. (2025). Matched unrelated vs haploidentical donor hematopoietic cell transplantation using posttransplant cyclophosphamide. Blood Advances. 10(1). 233–245. 1 indexed citations

Slade, Michael, et al.. (2024). Pretransplant desensitization of donor-specific anti-HLA antibodies with plasmapheresis and immunoglobulin produces equivalent outcomes to patients with no donor specific antibodies in haploidentical hematopoietic cell transplant. Leukemia & lymphoma. 65(12). 1811–1819. 2 indexed citations

Shaffer, Brian C., Mahasweta Gooptu, Todd E. DeFor, et al.. (2024). Post-Transplant Cyclophosphamide–Based Graft-Versus-Host Disease Prophylaxis Attenuates Disparity in Outcomes Between Use of Matched or Mismatched Unrelated Donors. Journal of Clinical Oncology. 42(28). 3277–3286. 20 indexed citations

Zeidan, Amer M., Ramzi Abboud, Christopher B. Benton, et al.. (2024). Trial in Progress: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 2 Study of AK117/Placebo in Combination with Azacitidine in Patients with Newly Diagnosed Higher-Risk Myelodysplastic Syndromes (AK117-205). Blood. 144(Supplement 1). 6705–6705. 2 indexed citations

Abboud, Ramzi, Mark A. Schroeder, Michael P. Rettig, et al.. (2024). Itacitinib for prevention of graft-versus-host disease and cytokine release syndrome in haploidentical transplantation. Blood. 145(13). 1382–1394. 1 indexed citations

Abboud, Ramzi, et al.. (2024). Janus kinase inhibition in the treatment and prevention of graft-versus-host disease. Frontiers in Immunology. 15. 1304065–1304065. 4 indexed citations

Gao, Feng, et al.. (2023). Impact of donor age and relationship on outcomes of peripheral blood haploidentical hematopoietic cell transplantation. Bone Marrow Transplantation. 58(8). 855–862. 14 indexed citations

Abboud, Ramzi, Sena Kim, Karl Staser, et al.. (2023). Baricitinib with cyclosporine eliminates acute graft rejection in fully mismatched skin and heart transplant models. Frontiers in Immunology. 14. 1264496–1264496. 3 indexed citations

O’Neal, Julie, Julie Ritchey, Ramzi Abboud, et al.. (2023). Targeting Distinct Epitopes of FCRL5 Using CAR-T Generated with Sequences Derived from Newly Identified FCRL5 Humanized Antibodies Resulted in Potent Anti-Myeloma Activity in Vitro and In Vivo. Blood. 142(Supplement 1). 1922–1922. 1 indexed citations

10.

Abboud, Ramzi, Feng Gao, Michael P. Rettig, et al.. (2022). A Single-Arm, Open-Label, Pilot Study of the JAK1 Selective Inhibitor Itacitinib for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome in T-Cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy. 28(3). S298–S299. 1 indexed citations

11.

Liu, Lawrence, Feng Gao, Ramzi Abboud, et al.. (2022). Letermovir Discontinuation at Day 100 After Allogeneic Stem Cell Transplant Is Associated With Increased CMV-Related Mortality. Transplantation and Cellular Therapy. 28(8). 510.e1–510.e9. 29 indexed citations

12.

O’Neal, Julie, Julie Ritchey, Matthew Cooper, et al.. (2022). CS1 CAR-T targeting the distal domain of CS1 (SLAMF7) shows efficacy in high tumor burden myeloma model despite fratricide of CD8+CS1 expressing CAR-T cells. Leukemia. 36(6). 1625–1634. 34 indexed citations

13.

Wan, Fei, et al.. (2022). The impact of tocilizumab treatment for cytokine release syndrome on the incidence of early blood stream infections after peripheral blood haploidentical hematopoietic cell transplantation. Leukemia & lymphoma. 63(12). 2975–2981. 3 indexed citations

14.

Abboud, Ramzi, Fei Wan, Jacopo Mariotti, et al.. (2021). Cytokine release syndrome after haploidentical hematopoietic cell transplantation: an international multicenter analysis. Bone Marrow Transplantation. 56(11). 2763–2770. 25 indexed citations

15.

Jacoby, Meagan A., David A. Sallman, Bart L. Scott, et al.. (2021). A Pilot Study of CPX-351 (Vyxeos ©) for Transplant Eligible, Higher Risk Patients with Myelodysplastic Syndrome. Blood. 138(Supplement 1). 540–540. 6 indexed citations

16.

Abboud, Ramzi, Feng Gao, Michael P. Rettig, et al.. (2021). A Single-Arm, Open-Label, Pilot Study of the JAK1 Selective Inhibitor Itacitinib for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome in T-Cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation. Blood. 138(Supplement 1). 100–100. 6 indexed citations

17.

Abboud, Ramzi, Michael Slade, Camille N. Abboud, John F. DiPersio, & Zhifu Xiang. (2020). Can Planned CD34+ Stem Cell Boost Prevent Poor Graft Function after Peripheral Blood Haploidentical Hematopoietic Transplantation?. Biology of Blood and Marrow Transplantation. 26(3). S296–S296. 2 indexed citations

18.

Russler‐Germain, David A., Ramzi Abboud, Peter Westervelt, et al.. (2019). Increased Early Mortality after Fludarabine and Melphalan Conditioning with Peripheral Blood Grafts in Haploidentical SCT with Post-Transplant Cyclophosphamide. Blood. 134(Supplement_1). 4496–4496. 1 indexed citations

19.

Abboud, Ramzi, Jesse Keller, Michael Slade, et al.. (2016). Severe Cytokine-Release Syndrome after T Cell–Replete Peripheral Blood Haploidentical Donor Transplantation Is Associated with Poor Survival and Anti–IL-6 Therapy Is Safe and Well Tolerated. Biology of Blood and Marrow Transplantation. 22(10). 1851–1860. 104 indexed citations

20.

Hassane, Duane C., Mónica L. Guzmán, Cheryl A. Corbett, et al.. (2008). Discovery of agents that eradicate leukemia stem cells using an in silico screen of public gene expression data. Blood. 111(12). 5654–5662. 145 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact